Concentration ofd-propranolol in cervico-vaginal mucus: targeting of a novel spermicide
Advances in Contraception · 1985
DOI: 10.1007/bf01849149 ↗At a glance
Journal article in Advances in Contraception, 1985. Written by R M Pearson and 3 co-authors. Major MEDLINE topics: Vagina. Cited 3 times so far (Crossref); 22 references.
Abstract (original language)
It may be possible to develop new contraceptives that can be administered by mouth and will exert their effects after concentration in cervico-vaginal mucus. D-Propranolol was administered in 80 mg doses by mouth to six healthy female volunteers. Samples of blood plasma and cervico-vaginal mucus were obtained before and on six occasions up to 24 hours after drug ingestion. D-Propranolol was concentrated in cervico-vaginal mucus. No changes in blood pressure, pulse, or forced expiratory peak flow (FEPF) were observed.
Subjects
MeSH terms (MEDLINE)
Substances
Cite
APA
Pearson, R. M., Ridgway, E. J., Johnston, A., & Vadukul, J. (1985). Concentration ofd-propranolol in cervico-vaginal mucus: targeting of a novel spermicide. Advances in Contraception. https://doi.org/10.1007/bf01849149
Vancouver
Pearson RM, Ridgway EJ, Johnston A, Vadukul J. Concentration ofd-propranolol in cervico-vaginal mucus: targeting of a novel spermicide. Advances in Contraception. 1985. doi:10.1007/bf01849149
BibTeX
@article{Pearson1985,
author = {Pearson, R M and Ridgway, E J and Johnston, A and Vadukul, J},
title = {Concentration ofd-propranolol in cervico-vaginal mucus: targeting of a novel spermicide},
journal = {Advances in Contraception},
year = {1985},
doi = {10.1007/bf01849149}
}
EUVIMED